Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in Balb/C mice

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Andújar, Isabel ^a   Ríos, José Luis ^a   Giner, Rosa María ^a   Miguel Cerdá, José ^a   Recio, María Del Carmen ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; SHIKONIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; FECES ANALYSIS; FEMALE; HISTOPATHOLOGY; LITHOSPERMUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RECTUM HEMORRHAGE; STRUCTURE ACTIVITY RELATION; ULCERATIVE COLITIS; WEIGHT REDUCTION;

EID: 84872789244     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/271606     Document Type: Article

References (52)

1. Kornbluth A., Sachar D. B., Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee. American Journal of Gastroenterology 2010 105 3 501 523 2-s2.0-77949271455 10.1038/ajg.2009.727
2. Stange E. F., Travis S. P. L., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., Feakins R., Fléjou J. F., Herfarth H., Hommes D. W., Kupcinskas L., Lakatos P. L., Mantzaris G. J., Schreiber S., Villanacci V., Warren B. F., European evidence-based Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. Journal of Crohn's and Colitis 2008 2 1 1 23 2-s2.0-38749106156 10.1016/j.crohns.2007.11.001 (Pubitemid 351179487)
3. Ghosh S., Mitchell R., Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey. Journal of Crohn's and Colitis 2007 1 1 10 20 2-s2.0-37249068050 10.1016/j.crohns.2007.06.005 (Pubitemid 350265728)
4. Lakatos P. L., Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World Journal of Gastroenterology 2006 12 38 6102 6108 2-s2.0-33750609696 (Pubitemid 44688157)
5. Bonen D. K., Cho J. H., The genetics of inflammatory bowel disease. Gastroenterology 2003 124 2 521 536 2-s2.0-0037308263 10.1053/gast.2003.50045 (Pubitemid 36169267)
6. Cario E., Barrier-protective function of intestinal epithelial Toll-like receptor 2. Mucosal Immunology 2008 1 1, supplement S62 S66 2-s2.0-54349106465 10.1038/mi.2008.47
7. López-Serrano P., Pérez-Calle J. L., Pérez- Fernández M. T., Fernández-Font J. M., Boixeda D. M., Fernández-Rodríguez C. M., Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scandinavian Journal of Gastroenterology 2010 45 12 1464 1471
8. Bernstein C. N., Blanchard J. F., Rawsthorne P., Yu N., The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. American Journal of Gastroenterology 2001 96 4 1116 1122 2-s2.0-0035044890 10.1016/S0002-9270(01)02319-X (Pubitemid 32319146)
9. Bernstein C. N., Wajda A., Blanchard J. F., The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005 129 3 827 836 2-s2.0-24144497765 10.1053/j.gastro.2005.06.021 (Pubitemid 41242675)
10. Lakatos P. L., Lakatos L., Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World Journal of Gastroenterology 2008 14 25 3937 3947 2-s2.0-53449086211 10.3748/wjg.14.3937
11. Sánchez-Muñoz F., Domínguez-López A., Yamamoto-Furusho J. K., Role of cytokines in inflammatory bowel disease. World Journal of Gastroenterology 2008 14 27 4280 4288
12. Bouguen G., Chevaux J. B., Peyrin-Biroulet L., Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World Journal of Gastroenterology 2011 17 5 547 556 2-s2.0-79952781337 10.3748/wjg.v17.i5.547
13. Sánchez-Fidalgo S., Cárdeno A., Villegas I., Talero E., de la Lastra C. A., Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. European Journal of Pharmacology 2010 633 1-3 78 84 2-s2.0-77949915935 10.1016/j.ejphar.2010.01.025
14. Atreya I., Atreya R., Neurath M. F., NF- B in inflammatory bowel disease. Journal of Internal Medicine 2008 263 6 591 596 2-s2.0-43549085501 10.1111/j.1365-2796.2008.01953.x (Pubitemid 351678589)
15. Kwon K. H., Murakami A., Tanaka T., Ohigashi H., Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochemical Pharmacology 2005 69 3 395 406 2-s2.0-11844279094 10.1016/j.bcp.2004.10.015 (Pubitemid 40094500)
16. Recio M. C., Andújar I., Rios J. L., Anti-inflammatory agents from plants: progress and potential. Current Medicinal Chemistry 2012 19 14 2088 2103
17. Maity S., Ukil A., Karmakar S., Datta N., Chaudhuri T., Vedasiromoni J. R., Ganguly D. K., Das P. K., Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. European Journal of Pharmacology 2003 470 1-2 103 112 2-s2.0-0038360968 10.1016/S0014-2999(03)01760-6 (Pubitemid 36638632)
18. Sugimoto K., Hanai H., Tozawa K., Aoshi T., Uchijima M., Nagata T., Koide Y., Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 2002 123 6 1912 1922 2-s2.0-0036892994 10.1053/gast.2002.37050 (Pubitemid 35408315)
19. Arafa H. M. M., Hemeida R. A., El-Bahrawy A. I. M., Hamada F. M. A., Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model. Food and Chemical Toxicology 2009 47 6 1311 1317 2-s2.0-67349227422 10.1016/j.fct.2009.03.003
20. González R., Ballester I., López-Posadas R., Suárez M. D., Zarzuelo A., Martínez-Augustin O., Sánchez de Medina F., Effects of flavonoids and other polyphenols on inflammation. Critical Reviews in Food Science and Nutrition 2011 51 4 331 362
21. Papageorgiou V. P., Assimopoulou A. N., Couladouros E. A., Hepworth D., Nicolaou K. C., The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products. Angewandte Chemie 1999 38 270 300 (Pubitemid 29090823)
22. Tan W., Lu J., Huang M., Li Y., Chen M., Wu G., Gong J., Zhong Z., Xu Z., Dang Y., Guo J., Chen X., Wang Y., Anti-cancer natural products isolated from chinese medicinal herbs. Chinese Medicine 2011 6, article 27 2-s2.0-79960555687 10.1186/1749-8546-6-27
23. Zeng Y. Q., Identificación y actividad farmacológica de principios de especies antiinflamatorias [Tesis Doctoral] 2006 Universidad de Valencia
24. Andújar I., Recio M. C., Bacelli T., Giner R. M., Ríos J. L., Shikonin reduces oedema induced by phorbol ester by interfering with I B degradation thus inhibiting translocation of NF- B to the nucleus. British Journal of Pharmacology 2010 160 2 376 388 2-s2.0-77951683909 10.1111/j.1476-5381.2010.00696.x
25. Cooper H. S., Murthy S. N. S., Shah R. S., Sedergran D. J., Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory Investigation 1993 69 2 238 250 2-s2.0-0027224059 (Pubitemid 23262505)
26. Tamaki H., Nakamura H., Nishio A., Nakase H., Ueno S., Uza N., Kido M., Inoue S., Mikami S., Asada M., Kiriya K., Kitamura H., Ohashi S., Fukui T., Kawasaki K., Matsuura M., Ishii Y., Okazaki K., Yodoi J., Chiba T., Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology 2006 131 4 1110 1121 2-s2.0-33749352225 10.1053/j.gastro.2006.08.023 (Pubitemid 44498706)
27. Suzuki K., Ota H., Sasagawa S., Sakatani T., Fujikura T., Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Analytical Biochemistry 1983 132 2 345 352 2-s2.0-0020550892 (Pubitemid 13048589)
28. Siegmund B., Lehr H. A., Fantuzzi G., Dinarello C. A., IL-1 β -converting enzyme (caspase-1) in intestinal inflammation. Proceedings of the National Academy of Sciences of the United States of America 2001 98 23 13249 13254 2-s2.0-0035818549 10.1073/pnas.231473998 (Pubitemid 33051348)
29. Grisham M. B., Johnson G. G., Lancaster J. R. Jr., Quantitation of nitrate and nitrite in extracellular fluids. Methods in Enzymology 1996 268 237 246 2-s2.0-0029837447 (Pubitemid 26286366)
30. Jurjus A. R., Khoury N. N., Reimund J. M., Animal models of inflammatory bowel disease. Journal of Pharmacological and Toxicological Methods 2004 50 2 81 92 2-s2.0-4644294467 10.1016/j.vascn.2003.12.002 (Pubitemid 39286320)
31. Papadakis K. A., Targan S. R., Role of cytokines in the pathogenesis of inflammatory bowel disease. Annual Review of Medicine 2000 51 289 298 2-s2.0-0034005581 10.1146/annurev.med.51.1.289 (Pubitemid 30216038)
32. Dai Q., Fang J., Zhang F. S., Dual role of shikonin in early and late stages of collagen type II arthritis. Molecular Biology Reports 2009 36 6 1597 1604 2-s2.0-67651108898 10.1007/s11033-008-9356-7
33. Alexander J. S., Chaitanya G. V., Grisham M. B., Boktor M., Emerging roles of lymphatics in inflammatory bowel disease. Annals of the New York Academy of Sciences 2010 1207, supplement 1 E75 E85 2-s2.0-78049509438 10.1111/j.1749-6632.2010.05757.x
34. Ghosh S., Hayden M. S., New regulators of NF- B in inflammation. Nature Reviews Immunology 2008 8 11 837 848 2-s2.0-54949147176 10.1038/nri2423
35. Schreiber S., Nikolaus S., Hampe J., Activation of nuclear factor B inflammatory bowel disease. Gut 1998 42 4 477 484 2-s2.0-0031925362 (Pubitemid 28186562)
36. Rogler G., Brand K., Vogl D., Page S., Hofmeister R., Andus T., Knuechel R., Baeuerle P. A., Scholmerich J., Gross V., Nuclear factor B is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998 115 2 357 369 2-s2.0-0031595210 10.1016/S0016-5085(98)70202-1 (Pubitemid 28363428)
37. Neurath M. F., Pettersson S., Meyer Zum Büschenfelde K. H., Strober W., Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF- B abrogates established experimental colitis in mice. Nature Medicine 1996 2 9 998 1004 2-s2.0-0029836444 10.1038/nm0996-998 (Pubitemid 26306838)
38. Spiik A. K., Ridderstad A., Axelsson L. G., Midtvedt T., Björk L., Pettersson S., Abrogated lymphocyte infiltration and lowered CD14 in dextran sulfate induced colitis in mice treated with p65 antisense oligonucleotides. International Journal of Colorectal Disease 2002 17 4 223 232 2-s2.0-0036935106 10.1007/s00384-001-0366-3 (Pubitemid 36075776)
39. Fichtner-Feigl S., Fuss I. J., Preise J. C., Strober W., Kitani A., Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF- B decoy oligonucleotides. Journal of Clinical Investigation 2005 115 11 3057 3071 2-s2.0-27644453163 10.1172/JCI24792 (Pubitemid 41567571)
40. Xiang J. Y., Wu L. G., Huang X. L., Zhang M., Pen L., Ouyan Q., Gan H. T., Amelioration of murine dextran sulfate sodium-induced colitis by nuclear factor- b decoy oligonucleotides. American Journal of Surgery 2009 197 6 797 805 2-s2.0-66149083594 10.1016/j.amjsurg.2008.04.012
41. Murano M., Maemura K., Hirata I., Toshina K., Nishikawa T., Hamamoto N., Sasaki S., Saitoh O., Katsu K., Therapeutic effect of intracolonically administered nuclear factor B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)- induced colitis. Clinical and Experimental Immunology 2000 120 1 51 58 2-s2.0-0034124076 (Pubitemid 30176899)
42. Chiu S. C., Tsao S. W., Hwang P. I., Vanisree S., Chen Y. A., Yang N. S., Differential functional genomic effects of anti-inflammatory phytocompounds on immune signaling. BMC Genomics 2010 11 1, article 513 2-s2.0-77956909628 10.1186/1471-2164-11-513
43. Lu L., Qin A., Huang H., Zhou P., Zhang C., Liu N., Li S., Wen G., Zhang C., Dong W., Wang X., Dou Q. P., Liu J., Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition. European Journal of Pharmacology 2011 658 2-3 242 247 2-s2.0-79953795868 10.1016/j.ejphar.2011.02.043
44. Fan Y., Zhang Y. L., Wu Y., Zhang W., Wang Y. H., Cheng Z. M., Li H., Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells. World Journal of Gastroenterology 2008 14 3 428 434 2-s2.0-40049093105 10.3748/wjg.14.428 (Pubitemid 351320852)
45. Mudter J., Weigmann B., Bartsch B., Kiesslich R., Strand D., Galle P. R., Lehr H. A., Schmidt J., Neurath M. F., Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. American Journal of Gastroenterology 2005 100 1 64 72 2-s2.0-13744249714 10.1111/j.1572-0241.2005.40615.x (Pubitemid 41623270)
46. Atreya R., Neurath M. F., Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Current Drug Targets 2008 9 5 369 374 2-s2.0-44949130806 10.2174/138945008784221116 (Pubitemid 352025210)
47. Li Y., de Haar C., Peppelenbosch M. P., van der Woude C. J., New insights into the role of STAT3 in IBD. Inflammatory Bowel Disease 2012 18 6 1177 1183
48. Lovato P., Brender C., Agnholt J., Kelsen J., Kaltoft K., Svejgaard A., Eriksen K. W., Woetmann A., Ødum N., Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. Journal of Biological Chemistry 2003 278 19 16777 16781 2-s2.0-0038269009 10.1074/jbc.M207999200 (Pubitemid 36799545)
49. Suzuki K., Sugimura K., Hasegawa K., Yoshida K., Suzuki A., Ishizuka K., Ohtsuka K., Honma T., Narisawa R., Asakura H., Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scandinavian Journal of Gastroenterology 2001 36 12 1301 1306 2-s2.0-17944370715 10.1080/003655201317097164 (Pubitemid 33027810)
50. Bai A. P., Hu P. J., Chen J., Song X., Chen W., Peng W. X., Zeng Z. R., Gao X., Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis. International Journal of Colorectal Disease 2007 22 6 625 635 2-s2.0-34547122473 10.1007/s00384-006-0229-z (Pubitemid 47097033)
51. Abraham C., Medzhitov R., Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011 140 6 1729 1737 2-s2.0-79955552936 10.1053/j.gastro.2011.02.012
52. Kuo H. M., Hsia T. C., Chuang Y. C., Lu H. F., Lin S. Y., Chung J. G., Shikonin inhibits the growth and N-acetylation of 2-aminofluorene in Helicobacter pylori from ulcer patients. Anticancer Research 2004 24 3 1587 1592 2-s2.0-3242684415